Comparison of topical ?% Methimazole and 4 % Hydroquinone effect on melasma
Phase 2
Recruiting
- Conditions
- melasma.L81.1Chloasma
- Registration Number
- IRCT20091012002581N9
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age higher than 18 years and below 50 years
Informed consent participate in the study
Presence of melanoma in both sides of cheeks
Exclusion Criteria
Lack of consent to participate in the study
Pregnancy or lactation
History of sensitivity to Tiamazoles
Thyroid dysfunction
History of using other topical drugs for melanoma in past 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of melasma lesions. Timepoint: 1, 4, 8 and 12 months after treatment. Method of measurement: Clinical examination and comparison of photos and use of Hemi Masi score.
- Secondary Outcome Measures
Name Time Method